FDA and NMPA Approve New State-of-the-Art Manufacturing Facility for Euclid Systems
Tuesday, August 27, 2019
The US FDA and Chinese Regulatory Authority (NMPA) have approved Euclid Systems Corporation, the Global Leader in Myopia Management and Advanced Orthokeratology, to manufacture the Euclid Emerald™ line of contact lenses in a new, state-of-the-art facility located in Sterling, Virginia. The new space is more than triple the size of the company’s current facility, allowing for Euclid to keep up with the growing worldwide demand of its advanced orthokeratology lens design.
“With this new, state-of-the art facility, Euclid has the space it needs to grow as we serve the rapidly expanding Orthokeratology market, providing improved vision and quality of life to kids around the world,” said Michael Ross, chairman and chief executive officer, Euclid Systems Corporation.
Euclid also plans to transition to a custom automated platform for manufacturing, which will help the company better serve its customer base around the world.
The announcement of the new facility comes on the heels of Euclid receiving the prestigious award of “Public Trusted Brand” by the 11th Healthy China Forum earlier this year. The award is a testament to the company’s devotion to helping more children around the world realize their full potential through Proactive Myopia Management.
“The approval of our Sterling manufacturing facility comes at a critical time of increasing awareness of myopia as a global epidemic, global demand and increased interest on the quality and safety of Euclid’s products,” said Sandra Gilbert, vice president, global quality and regulatory compliance, Euclid Systems Corporation.